Health Biotechnology and Biopharma Journal(HBB) is a Quarterly peer-reviewed journal which publishes original research papers,review articles and short communications on all areas of health biotechnology and biopharma. It aims to disseminate knowledge, provide a learned reference in the field, and establ...
Pharma companies are constantly on the quest to discover the next big game-changer drug or therapeutic by leveraging the latest, cutting-edge innovation. While it is notable that biopharma companies eased up on their research and development (R&D) spending in FY 2022-23 after the world was hit...
Nature Biotechnology volume 40, pages 821–828 (2022)Cite this article 13k Accesses 3 Citations 65 Altmetric Metrics details A survey of national R&D-driven health biotech sectors ranks Switzerland, Sweden and the United States as leading centers for R&D-driven biotech. John Hodgson and Deanna ...
Indian healthcare system is in immediate need of a new healthcare delivery model to increase healthcare accessibility and improve the health outcomes of the marginalized. Inaccessibility and underutilization of Primary Health Centers (PHCs) disproportionately affect people living in remote areas. It is...
The Dawn of China Biopharma Innovation. Volume 29. McKinsey and Company; 2021. National Health and Family Planning Commission. Major New Drug Development’, Major Science and Technology Special projects Eligible for Rolling Support in 2016. Beijing: National Health and Family Planning Commission; 2016...
Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine lea
Since the 1970s, the establishment and development of the biotech industry has improved exponentially, allowing the commercial production of biopharmaceuti... Daniel,Weinacker,Claudia,... - 《Brazilian Journal of Microbiology》 被引量: 41发表: 2013年 Production and characterization of the Talaromyces...
developed a research paper which sets out to consider what the life science, biopharma R&D and healthcare ecosystem might look like in 2030. This paper was developed with the input of global healthcare, biopharma and digital experts, during a series of face-to-face meetings in the US and ...
Scholars previously estimated research and development (R&D) costs of the internal drug development process. However, little is known about the costs and value arising from externally acquired therapeutics. This study identifies and estimates the magnitude of factors associated with Biopharma acquisition va...
The term biopharma captures a broadening of discussion about pharmaceutical policy and the growing significance of biotechnology. Indeed, the commercialisation of the discoveries of the biological sciences, oriented towards an understanding of living cells at the molecular level, is widely seen as potentia...